FibroGen Stock News

FibroGen, Inc. (NASDAQ:FGEN ) Q2 2022 Earnings Conference Call August 8, 2022 5:00 PM ET Company Participants Michael Tung - Corporate Strategy and IR Enrique Conterno - CEO Mark Eisner - Chief Medica

FibroGen (FGEN) delivered earnings and revenue surprises of 17.02% and 18.57%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

SAN FRANCISCO, July 25, 2022 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce its second quarter 2022 financial results on Monday, August 8 after the market close. FibroGen will also co

SAN FRANCISCO, May 26, 2022 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that Enrique Conterno, Chief Executive Officer, will participate in a fireside chat at the Jefferies Healt

Should investors pay more attention to these biotech stocks?

FibroGen, Inc. (NASDAQ:FGEN ) Q1 2022 Earnings Conference Call May 9, 2022 5:00 PM ET Company Participants Michael Tung – Corporate Strategy/Investor Relations Enrique Conterno – Chief Executive O

FibroGen (FGEN) delivered earnings and revenue surprises of 19.05% and 120.72%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

FibroGen (FGEN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SAN FRANCISCO, April 25, 2022 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce its first quarter 2022 financial results on Monday, May 9 after the market close. FibroGen will also condu

FibroGen Inc. (NASDAQ:FGEN)’s traded shares stood at 0.77 million during the last session, with the company’s beta value hitting 0.80. At the close of trading, the stock’s price was $12.98, to imply a decrease of -1.37% or -$0.18 in intraday trading. The FGEN share’s 52-week high remains $36.12, putting it -178.27% down since that peak … Boom Or Bust: What Are FibroGen Inc.’s (NASDAQ:FGEN) Future Prospects? Read More »

FibroGen, Inc. (NASDAQ: FGEN) Q4 2021 earnings call dated Feb. 28, 2022 Corporate Participants: Michael Tung — Vice President, Corporate Strategy & Investor Relations Enrique Conterno — Chief Executive Officer Juan Graham — Chief Financial Officer […] The post FibroGen, Inc. (FGEN) Q4 2021 Earnings Call Transcript first appeared on AlphaStreet .

FibroGen, Inc. (FGEN) CEO Enrique Conterno on Q4 2021 Results - Earnings Call Transcript